-
Represents Technology and Life Sciences Innovators
Ali has worked with innovators engaged in highly technical fields, including diagnostics, genomics, bioinformatics, artificial intelligence, and materials.
-
Informed Technical Experience
Prior to joining the firm, Ali worked on data warehousing, business intelligence, and enterprise data integration.
-
IP Instruction Efforts
Ali frequently lectures at the UC Berkeley School of Law and University of California College of the Law, San Francisco, on IP topics, including patent strategy and IP due diligence.
Dr. Ali R. Alemozafar is a partner at Wilson Sonsini Goodrich & Rosati, where he leads the tools, diagnostics, and deep technology practice in the Patents and Innovations group. He counsels companies and venture capital firms on strategic intellectual property matters across a broad range of technical fields, including diagnostics, life science tools, genomics, bioinformatics, digital health, quantum computing, artificial intelligence, advanced materials, and engineering.
Ali holds a Ph.D. from Stanford University and completed a postdoctoral fellowship at Harvard University, bringing deep scientific and engineering expertise to his legal practice.
His strategic approach to patent prosecution has secured patents that have been successfully enforced and have withstood post-grant challenges, including inter partes reviews.
Ali’s practice includes patent strategy, global patent prosecution, and IP due diligence—including freedom-to-operate analyses—for venture financings, mergers and acquisitions, and public offerings. He has prosecuted patent applications in the United States, Europe, China, Japan, and other jurisdictions. He counsels companies from early-stage start-ups through IPO and beyond.
Ali has taught courses on patent strategy and IP due diligence at UC Berkeley Law. He also serves on the advisory group at UC Berkeley Bakar Bio Labs.
Dr. Ali R. Alemozafar is a partner at Wilson Sonsini Goodrich & Rosati, where he leads the tools, diagnostics, and deep technology practice in the Patents and Innovations group. He counsels companies and venture capital firms on strategic intellectual property matters across a broad range of technical fields, including diagnostics, life science tools, genomics, bioinformatics, digital health, quantum computing, artificial intelligence, advanced materials, and engineering.
Ali holds a Ph.D. from Stanford University and completed a postdoctoral fellowship at Harvard University, bringing deep scientific and engineering expertise to his legal practice.
His strategic approach to patent prosecution has secured patents that have been successfully enforced and have withstood post-grant challenges, including inter partes reviews.
Ali’s practice includes patent strategy, global patent prosecution, and IP due diligence—including freedom-to-operate analyses—for venture financings, mergers and acquisitions, and public offerings. He has prosecuted patent applications in the United States, Europe, China, Japan, and other jurisdictions. He counsels companies from early-stage start-ups through IPO and beyond.
Ali has taught courses on patent strategy and IP due diligence at UC Berkeley Law. He also serves on the advisory group at UC Berkeley Bakar Bio Labs.
- J.D., University of California College of the Law, San Francisco
- Postdoctoral Research Fellowship, Department of Chemistry and Chemical Biology, Harvard University
- Ph.D., Chemical Engineering, Stanford University
- B.S., Chemical Engineering, Cornell University
- Recognized in the 2026 edition of Chambers USA for Intellectual Property: Patent Prosecution in California
- State Bar of California
- U.S. Patent and Trademark Office
- J.D., University of California College of the Law, San Francisco
- Postdoctoral Research Fellowship, Department of Chemistry and Chemical Biology, Harvard University
- Ph.D., Chemical Engineering, Stanford University
- B.S., Chemical Engineering, Cornell University
- Recognized in the 2026 edition of Chambers USA for Intellectual Property: Patent Prosecution in California
- State Bar of California
- U.S. Patent and Trademark Office
Select Life Sciences Representations
- Element Biosciences in intellectual property matters
- Ultima Genomics in intellectual property matters
- Apton Biosciences in intellectual property matters leading to acquisition by Pacific Biosciences of California (PacBio)
- 10X Genomics in intellectual property matters leading to its IPO
- Metagenomi in intellectual property matters
- Genia Technologies in intellectual property and licensing matters, leading to its acquisition by Roche
- Cirina in intellectual property matters leading to its acquisition by Grail
- Veracyte in intellectual property matters leading to its IPO
- GenapSys in intellectual property matters
- Guardant Health in intellectual property matters leading to its IPO
- Personalis in intellectual property matters leading to its IPO
Select Technology Representations
- Velo3D in intellectual property matters
- Holo in intellectual property matters
- 1Qbit in intellectual property matters
- Ambri in intellectual property matters
Select Life Sciences Representations
- Element Biosciences in intellectual property matters
- Ultima Genomics in intellectual property matters
- Apton Biosciences in intellectual property matters leading to acquisition by Pacific Biosciences of California (PacBio)
- 10X Genomics in intellectual property matters leading to its IPO
- Metagenomi in intellectual property matters
- Genia Technologies in intellectual property and licensing matters, leading to its acquisition by Roche
- Cirina in intellectual property matters leading to its acquisition by Grail
- Veracyte in intellectual property matters leading to its IPO
- GenapSys in intellectual property matters
- Guardant Health in intellectual property matters leading to its IPO
- Personalis in intellectual property matters leading to its IPO
Select Technology Representations
- Velo3D in intellectual property matters
- Holo in intellectual property matters
- 1Qbit in intellectual property matters
- Ambri in intellectual property matters
Select Publications
- Co-author with V. Norviel and R. Akhavan, "Role of intellectual property in investment-backed personalized medicine," 7(1) Personalized Medicine 95-102, 2010
- Co-author with B.K. Min, X. Deng, X. Liu, and C.M. Friend, "Tuning reactivity and selectivity for olefin oxidation through local O bonding on Au," 1 ChemCatChem 116-121, 2009
- Co-author with B.K. Min, M.M. Biener, J. Biener, and C.M. Friend, "Reaction of Au(111) with Sulfur and Oxygen: Scanning Tunneling Microscopy Study," 36 Topics in Catalysis 77, 2005
- Co-author with R.J. Madix, "An STM investigation of sulfur and alkoxide adsorption on Ni(100)," 109 The Journal of Physical Chemistry B 11307, 2005
- Co-author with R.J. Madix, "Surface reorganization accompanying the formation of sulfite and sulfate by reaction of sulfur dioxide with oxygen on Ag(111)," The Journal of Chemical Physics 122 (2005) 214718, 2005
- Co-author with R.J. Madix, "The Role of Surface Deconstruction in the Autocatalytic Decomposition of Formate and Acetate on Ni(110)," 108 The Journal of Physical Chemistry B 14374, 2004
- Co-author with R.J. Madix, "CO-Induced Segregation of Hydrogen into the Subsurface on Ni(110)," 108 The Journal of Physical Chemistry B 7247, 2004
- Co-author with X.-C. Guo and R.J. Madix, "Adsorption and Reaction of Sulfur Dioxide with Cu(110) and Cu(110)-p(2x1)-O," 116 The Journal of Chemical Physics 4698, 2002
Select Publications
- Co-author with V. Norviel and R. Akhavan, "Role of intellectual property in investment-backed personalized medicine," 7(1) Personalized Medicine 95-102, 2010
- Co-author with B.K. Min, X. Deng, X. Liu, and C.M. Friend, "Tuning reactivity and selectivity for olefin oxidation through local O bonding on Au," 1 ChemCatChem 116-121, 2009
- Co-author with B.K. Min, M.M. Biener, J. Biener, and C.M. Friend, "Reaction of Au(111) with Sulfur and Oxygen: Scanning Tunneling Microscopy Study," 36 Topics in Catalysis 77, 2005
- Co-author with R.J. Madix, "An STM investigation of sulfur and alkoxide adsorption on Ni(100)," 109 The Journal of Physical Chemistry B 11307, 2005
- Co-author with R.J. Madix, "Surface reorganization accompanying the formation of sulfite and sulfate by reaction of sulfur dioxide with oxygen on Ag(111)," The Journal of Chemical Physics 122 (2005) 214718, 2005
- Co-author with R.J. Madix, "The Role of Surface Deconstruction in the Autocatalytic Decomposition of Formate and Acetate on Ni(110)," 108 The Journal of Physical Chemistry B 14374, 2004
- Co-author with R.J. Madix, "CO-Induced Segregation of Hydrogen into the Subsurface on Ni(110)," 108 The Journal of Physical Chemistry B 7247, 2004
- Co-author with X.-C. Guo and R.J. Madix, "Adsorption and Reaction of Sulfur Dioxide with Cu(110) and Cu(110)-p(2x1)-O," 116 The Journal of Chemical Physics 4698, 2002
Biological Sciences and Biotechnology
- Biochemical assays
- Biophysics
- Cancer biology
- Cell biology
- Cellular biology
- Epigenetics
- Genetics
- Genomics
- Microbiology
- MicroRNA (miRNA) research
- Molecular biology
- Molecular genetics
- PCR
- Proteomics
Therapeutics and Drug Discovery
- Drug delivery
- Gene editing
- Gene therapy
- Vaccines
Diagnostics and Medical Devices
- Bioinformatic
- Biomedical devices
- Biomedical engineering
- Biosensors
- Diagnostics
- Digital pathology
- Medical devices
- Medical imaging
- miRNA detection
- Neuroimaging
- Point-of-care testing (POCT)
- Telemedicine technology
- Wearable analyte sensors
Chemistry and Material Science
- Catalysis
- Chemical synthesis
- Chemistry
- Green chemistry
- Materials chemistry
- Nanochemistry
- Photovoltaic materials
- Polymers
Engineering and Technology
- 3D bioprinting
- AI
- Biomechanics
- Computer science
- Electrical engineering
- Machine learning
- Materials science
- Mechanical engineering
- Microfluidics
- Nanorobotics
- Robotics
Genomics and Data Analysis
- Bioinformatics algorithms
- Computational biology
- Functional genomics
- Next-generation sequencing
- rDNA
- Sequencing
- shRNA
- Single-Cell sequencing
Miscellaneous
- Cancer
- Design patent
- Engineered foods
- Fluorescence microscopy
- Food science
- Formulations
- Physics
- Psychology
Biological Sciences and Biotechnology
- Biochemical assays
- Biophysics
- Cancer biology
- Cell biology
- Cellular biology
- Epigenetics
- Genetics
- Genomics
- Microbiology
- MicroRNA (miRNA) research
- Molecular biology
- Molecular genetics
- PCR
- Proteomics
Therapeutics and Drug Discovery
- Drug delivery
- Gene editing
- Gene therapy
- Vaccines
Diagnostics and Medical Devices
- Bioinformatic
- Biomedical devices
- Biomedical engineering
- Biosensors
- Diagnostics
- Digital pathology
- Medical devices
- Medical imaging
- miRNA detection
- Neuroimaging
- Point-of-care testing (POCT)
- Telemedicine technology
- Wearable analyte sensors
Chemistry and Material Science
- Catalysis
- Chemical synthesis
- Chemistry
- Green chemistry
- Materials chemistry
- Nanochemistry
- Photovoltaic materials
- Polymers
Engineering and Technology
- 3D bioprinting
- AI
- Biomechanics
- Computer science
- Electrical engineering
- Machine learning
- Materials science
- Mechanical engineering
- Microfluidics
- Nanorobotics
- Robotics
Genomics and Data Analysis
- Bioinformatics algorithms
- Computational biology
- Functional genomics
- Next-generation sequencing
- rDNA
- Sequencing
- shRNA
- Single-Cell sequencing
Miscellaneous
- Cancer
- Design patent
- Engineered foods
- Fluorescence microscopy
- Food science
- Formulations
- Physics
- Psychology
- Artificial Intelligence and Machine Learning
- Biotech
- Clean Energy
- Climate and Clean Technologies
- Data Storage and Cloud
- Diagnostics, Life Science Tools, and Deep Tech
- Digital Health
- Intellectual Property
- Life Sciences
- Medical Devices
- Mobile Devices
- Mobility
- Patents and Innovations
- Quantum Computing
- Semiconductors
- Software
Monday, June 16, 2025
Boston Convention & Exhibition Center
Boston, MA
3:00 - 4:00 PM ET
Click here for more information
- Privacy Policy
- Terms of Use
- Accessibility